🔗 Visit the ClinicalTrials.gov page for NCT00217412
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report. | J Clin Oncol | 2010 | 1.42 |
| 2 | A review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma. | Front Oncol | 2013 | 0.95 |
| 3 | Retinoid receptor signaling and autophagy in acute promyelocytic leukemia. | Exp Cell Res | 2014 | 0.93 |
| 4 | The rationale for targeted therapies in medulloblastoma. | Neuro Oncol | 2013 | 0.92 |
| 5 | Targeting epigenetics through histone deacetylase inhibitors in acute lymphoblastic leukemia. | Curr Cancer Drug Targets | 2011 | 0.78 |
| 6 | A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report. | Clin Cancer Res | 2014 | 0.77 |
| 7 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |